Subcutaneous implants for long-acting drug therapy in laboratory animals may generate unintended drug reservoirs
Author(s) -
Michael Guarnieri,
BettyM Tyler,
Louis J. DeTolla,
Ming Zhao,
Barry Kobrin
Publication year - 2014
Publication title -
journal of pharmacy and bioallied sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.268
H-Index - 36
eISSN - 0976-4879
pISSN - 0975-7406
DOI - 10.4103/0975-7406.124315
Subject(s) - drug , implant , medicine , bioavailability , pharmacology , drug delivery , pharmacokinetics , surgery , chemistry , organic chemistry
Long-acting therapy in laboratory animals offers advantages over the current practice of 2-3 daily drug injections. Yet little is known about the disintegration of biodegradable drug implants in rodents.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom